European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update

2022428 citationsReviewgold Open Access

Authors

Monoclonal antibodies targeting the CGRP pathway are recommended for migraine prevention as they are effective and safe also in the long-term.

Published in: The Journal of Headache and Pain

Volume 23, Issue 1, pp. 67-67

Field-Weighted Citation Impact: 60.61